Mankind Pharma Ltd
NSE:MANKIND
Wall Street
Price Targets
MANKIND Price Targets Summary
Mankind Pharma Ltd
According to Wall Street analysts, the average 1-year price target for MANKIND is 2 569.14 INR with a low forecast of 2 009.9 INR and a high forecast of 3 255 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MANKIND's stock price target?
Price Target
2 569.14
INR
According to Wall Street analysts, the average 1-year price target for MANKIND is 2 569.14 INR with a low forecast of 2 009.9 INR and a high forecast of 3 255 INR.
What is Mankind Pharma Ltd's Revenue forecast?
Projected CAGR
14%
For the last 4 years the compound annual growth rate for Mankind Pharma Ltd's revenue is 18%. The projected CAGR for the next 3 years is 14%.
What is Mankind Pharma Ltd's Operating Income forecast?
Projected CAGR
17%
For the last 4 years the compound annual growth rate for Mankind Pharma Ltd's operating income is 12%. The projected CAGR for the next 3 years is 17%.
What is Mankind Pharma Ltd's Net Income forecast?
Projected CAGR
15%
For the last 4 years the compound annual growth rate for Mankind Pharma Ltd's net income is 12%. The projected CAGR for the next 3 years is 15%.
